vs
Side-by-side financial comparison of Cintas (CTAS) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
Cintas is the larger business by last-quarter revenue ($2.8B vs $1.5B, roughly 1.9× BeOne Medicines Ltd.). Cintas runs the higher net margin — 17.7% vs 4.4%, a 13.3% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 9.3%). Cintas produced more free cash flow last quarter ($425.0M vs $379.8M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 7.9%).
Cintas Corporation is an American corporation headquartered in Mason, Ohio, which provides a range of products and services to businesses including uniforms, mats, mops, cleaning and restroom supplies, first aid and safety products, fire extinguishers and testing, and safety courses. Cintas is a publicly held company traded on the Nasdaq Global Select Market under the symbol CTAS and is a component of the S&P 500 Index.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
CTAS vs ONC — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.8B | $1.5B |
| Net Profit | $495.3M | $66.5M |
| Gross Margin | 50.4% | 90.5% |
| Operating Margin | 23.4% | 12.4% |
| Net Margin | 17.7% | 4.4% |
| Revenue YoY | 9.3% | 32.8% |
| Net Profit YoY | 10.4% | 143.8% |
| EPS (diluted) | $1.21 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.8B | $1.5B | ||
| Q3 25 | $2.7B | $1.4B | ||
| Q2 25 | $2.7B | $1.3B | ||
| Q1 25 | $2.6B | $1.1B | ||
| Q4 24 | $2.6B | $1.1B | ||
| Q3 24 | $2.5B | $1.0B | ||
| Q2 24 | $2.5B | $929.2M | ||
| Q1 24 | $2.4B | $751.7M |
| Q4 25 | $495.3M | $66.5M | ||
| Q3 25 | $491.1M | $124.8M | ||
| Q2 25 | $448.3M | $94.3M | ||
| Q1 25 | $463.5M | $1.3M | ||
| Q4 24 | $448.5M | $-151.9M | ||
| Q3 24 | $452.0M | $-121.3M | ||
| Q2 24 | $414.3M | $-120.4M | ||
| Q1 24 | $397.6M | $-251.2M |
| Q4 25 | 50.4% | 90.5% | ||
| Q3 25 | 50.3% | 86.1% | ||
| Q2 25 | 49.7% | 87.5% | ||
| Q1 25 | 50.6% | 85.2% | ||
| Q4 24 | 49.8% | 85.8% | ||
| Q3 24 | 50.1% | 83.0% | ||
| Q2 24 | — | 85.1% | ||
| Q1 24 | — | 83.4% |
| Q4 25 | 23.4% | 12.4% | ||
| Q3 25 | 22.7% | 11.5% | ||
| Q2 25 | 22.4% | 6.7% | ||
| Q1 25 | 23.4% | 1.0% | ||
| Q4 24 | 23.1% | -7.0% | ||
| Q3 24 | 22.4% | -12.0% | ||
| Q2 24 | 22.2% | -11.5% | ||
| Q1 24 | 21.6% | -34.8% |
| Q4 25 | 17.7% | 4.4% | ||
| Q3 25 | 18.1% | 8.8% | ||
| Q2 25 | 16.8% | 7.2% | ||
| Q1 25 | 17.8% | 0.1% | ||
| Q4 24 | 17.5% | -13.5% | ||
| Q3 24 | 18.1% | -12.1% | ||
| Q2 24 | 16.8% | -13.0% | ||
| Q1 24 | 16.5% | -33.4% |
| Q4 25 | $1.21 | $0.05 | ||
| Q3 25 | $1.20 | $0.08 | ||
| Q2 25 | $1.08 | $0.06 | ||
| Q1 25 | $1.13 | $0.00 | ||
| Q4 24 | $1.09 | $-0.10 | ||
| Q3 24 | $1.10 | $-0.09 | ||
| Q2 24 | $4.00 | $-0.09 | ||
| Q1 24 | $3.84 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $200.8M | $4.5B |
| Total DebtLower is stronger | $2.4B | $836.4M |
| Stockholders' EquityBook value | $4.5B | $4.4B |
| Total Assets | $10.1B | $8.2B |
| Debt / EquityLower = less leverage | 0.54× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $200.8M | $4.5B | ||
| Q3 25 | $138.1M | $4.0B | ||
| Q2 25 | $264.0M | $2.8B | ||
| Q1 25 | $243.4M | $2.5B | ||
| Q4 24 | $122.4M | $2.6B | ||
| Q3 24 | $101.4M | $2.7B | ||
| Q2 24 | $342.0M | $2.6B | ||
| Q1 24 | $128.5M | $2.8B |
| Q4 25 | $2.4B | $836.4M | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.4B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $2.5B | — |
| Q4 25 | $4.5B | $4.4B | ||
| Q3 25 | $4.8B | $4.1B | ||
| Q2 25 | $4.7B | $3.8B | ||
| Q1 25 | $4.6B | $3.5B | ||
| Q4 24 | $4.3B | $3.3B | ||
| Q3 24 | $4.0B | $3.4B | ||
| Q2 24 | $4.3B | $3.4B | ||
| Q1 24 | $4.2B | $3.4B |
| Q4 25 | $10.1B | $8.2B | ||
| Q3 25 | $9.8B | $7.6B | ||
| Q2 25 | $9.8B | $6.3B | ||
| Q1 25 | $9.6B | $5.8B | ||
| Q4 24 | $9.4B | $5.9B | ||
| Q3 24 | $9.1B | $5.8B | ||
| Q2 24 | $9.2B | $5.7B | ||
| Q1 24 | $9.0B | $5.7B |
| Q4 25 | 0.54× | 0.19× | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | 0.52× | — | ||
| Q1 25 | 0.44× | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.50× | — | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.58× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $531.2M | $417.3M |
| Free Cash FlowOCF − Capex | $425.0M | $379.8M |
| FCF MarginFCF / Revenue | 15.2% | 25.4% |
| Capex IntensityCapex / Revenue | 3.8% | 2.5% |
| Cash ConversionOCF / Net Profit | 1.07× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $1.8B | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $531.2M | $417.3M | ||
| Q3 25 | $414.5M | $402.6M | ||
| Q2 25 | $635.7M | $263.6M | ||
| Q1 25 | $622.0M | $44.1M | ||
| Q4 24 | $441.4M | $75.2M | ||
| Q3 24 | $466.7M | $188.4M | ||
| Q2 24 | $693.0M | $-95.6M | ||
| Q1 24 | $657.1M | $-308.6M |
| Q4 25 | $425.0M | $379.8M | ||
| Q3 25 | $312.5M | $354.5M | ||
| Q2 25 | $521.1M | $219.8M | ||
| Q1 25 | $522.1M | $-12.3M | ||
| Q4 24 | $340.0M | $-17.3M | ||
| Q3 24 | $373.8M | $54.7M | ||
| Q2 24 | $591.1M | $-205.5M | ||
| Q1 24 | $550.1M | $-465.1M |
| Q4 25 | 15.2% | 25.4% | ||
| Q3 25 | 11.5% | 25.1% | ||
| Q2 25 | 19.5% | 16.7% | ||
| Q1 25 | 20.0% | -1.1% | ||
| Q4 24 | 13.3% | -1.5% | ||
| Q3 24 | 14.9% | 5.5% | ||
| Q2 24 | 23.9% | -22.1% | ||
| Q1 24 | 22.9% | -61.9% |
| Q4 25 | 3.8% | 2.5% | ||
| Q3 25 | 3.8% | 3.4% | ||
| Q2 25 | 4.3% | 3.3% | ||
| Q1 25 | 3.8% | 5.0% | ||
| Q4 24 | 4.0% | 8.2% | ||
| Q3 24 | 3.7% | 13.3% | ||
| Q2 24 | 4.1% | 11.8% | ||
| Q1 24 | 4.4% | 20.8% |
| Q4 25 | 1.07× | 6.28× | ||
| Q3 25 | 0.84× | 3.22× | ||
| Q2 25 | 1.42× | 2.79× | ||
| Q1 25 | 1.34× | 34.71× | ||
| Q4 24 | 0.98× | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 1.67× | — | ||
| Q1 24 | 1.65× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTAS
| Uniform Rental And Facility Services Segment | $2.2B | 77% |
| First Aid And Safety Services Segment | $342.2M | 12% |
| Fire Protection Services | $222.5M | 8% |
| Uniform Direct Sales | $79.8M | 3% |
ONC
Segment breakdown not available.
